These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24468722)

  • 1. EU member state government contribution to alternative methods.
    Taylor K
    ALTEX; 2014; 31(2):215-8. PubMed ID: 24468722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fourth EU report on the statistics on the number of animals used for scientific purposes in 2002 -- trends, problems, conclusions.
    Sauer UG; Spielmann H; Rusche B
    ALTEX; 2005; 22(2):59-67. PubMed ID: 15953963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment).
    Spielmann H; Grune B; Liebsch M; Seiler A; Vogel R
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):225-33. PubMed ID: 18440212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
    Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
    Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EU research activities in alternative testing strategies: current status and future perspectives.
    Vanhaecke T; Snykers S; Rogiers V; Garthoff B; Castell JV; Hengstler JG
    Arch Toxicol; 2009 Dec; 83(12):1037-42. PubMed ID: 19908029
    [No Abstract]   [Full Text] [Related]  

  • 8. Open letter to the German Chancellor Dr. Angela Merkel. Council Directive on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes.
    Simons KW
    ALTEX; 2010; 27(1):70-3. PubMed ID: 20397315
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent developments in the way forward for alternative methods: formation of national consensus platforms in Europe.
    Rogiers V
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):408-13. PubMed ID: 16055162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The patchwork of toxicological research for pharmaceutical testing.
    von Aulock S
    ALTEX; 2010; 27(1):1. PubMed ID: 20397314
    [No Abstract]   [Full Text] [Related]  

  • 11. Inconsistencies in data requirements of EU legislation involving tests on animals.
    Wagner K; Fach B; Kolar R
    ALTEX; 2012; 29(3):302-32. PubMed ID: 22847257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 7th Amendment to the Cosmetics Directive.
    Ruet Rossignol M
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():19-20. PubMed ID: 16194137
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated decision-tree testing strategies for skin corrosion and irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():65-74. PubMed ID: 19025332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the revised Directive 2010/63/EU for the protection of laboratory animals with its predecessor 86/609/EEC - a t4 report.
    Hartung T
    ALTEX; 2010; 27(4):285-303. PubMed ID: 21240470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chair on alternatives?
    Spielmann H
    ALTEX; 2002; 19(2):69-73. PubMed ID: 12098012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third EU report on the statistics on animals used for experimental and other scientific purposes: trends, problems, conclusions.
    Sauer UG; Spielmann H; Rusche B
    Altern Lab Anim; 2004 Sep; 32(3):309-17. PubMed ID: 15588169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ecopa: a powerful concept in the way forward for alternative methods.
    Rogiers V
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():199-202. PubMed ID: 12513674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal use for science in Europe.
    Daneshian M; Busquet F; Hartung T; Leist M
    ALTEX; 2015; 32(4):261-74. PubMed ID: 26536288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.